Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of in Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

NCT00631072 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00631072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00631072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of in Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
April 30, 2015
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma